EMA — Withdrawn Medicines & Recalls (FDA MedWatch)

EMA — Withdrawn Medicines & Recalls is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.fda.gov

Country

United States

Notices tracked by Mederti

2,536

Last checked

15 Sept 2026

Latest notices from FDA MedWatch

• Ramipril — active, high, since 24 Aug 2026 (source)
• Zicam Nasal Allclear — active, high, since 10 Aug 2026 (source)
• Carbamazepine Oral Suspension Usp — active, high, since 7 Aug 2026 (source)
• Levothyroxine Sodium Tablets — active, high, since 6 Aug 2026 (source)
• Acthar Gel (Repository Corticotropin Injection) 400 Usp Units/5Ml (80 Usp Units/ — active, high, since 6 Aug 2026 (source)
• Mirabegron — active, high, since 5 Aug 2026 (source)
• Clobetasol Propionate Cream Usp — active, high, since 3 Aug 2026 (source)
• Sildenafilo Aristo — active, high, since 3 Aug 2026 (source)
• Tadalafil — active, high, since 3 Aug 2026 (source)
• Optiray Ultraject — active, critical, since 31 Jul 2026 (source)
• Clindamycin-Hydrochloride — active, high, since 30 Jul 2026 (source)
• Pemrydi Rtu (Pemetrexed Injection) — active, high, since 29 Jul 2026 (source)
• Clear (Benzoyl Peroxide 3.75% — active, high, since 29 Jul 2026 (source)
• Semaglutide — active, high, since 29 Jul 2026 (source)
• Cefazolin All Strengths — active, medium, since 24 Jul 2026 (source)

Mederti is not affiliated with or endorsed by EMA — Withdrawn Medicines & Recalls. All notices remain the property of their publisher and are linked to the original source.